| scholarly article | Q13442814 |
| P50 | author | Barton Haynes | Q4865631 |
| Georgia D. Tomaras | Q63663866 | ||
| P2860 | cites work | Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals | Q24635002 |
| HIV‐1 neutralizing antibodies: understanding nature's pathways | Q27000480 | ||
| Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus | Q27644501 | ||
| Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies | Q27644515 | ||
| Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization | Q27677117 | ||
| Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike | Q27683540 | ||
| Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers | Q27683553 | ||
| Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization | Q27684578 | ||
| Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target | Q29547347 | ||
| Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection | Q33702217 | ||
| Early development of broadly neutralizing antibodies in HIV-1-infected infants | Q33764917 | ||
| Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals | Q34962766 | ||
| The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection | Q35076717 | ||
| Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors | Q35382871 | ||
| Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape | Q36388754 | ||
| Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection | Q37033294 | ||
| Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers | Q39001126 | ||
| Opening Fronts in HIV Vaccine Development: Tracking the development of broadly neutralizing antibodies | Q50617948 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 583-585 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Nature medicine | Q1633234 |
| P1476 | title | Lessons from babies: inducing HIV-1 broadly neutralizing antibodies | |
| P478 | volume | 20 |
Search more.